Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-20T17:03:02.477Z Has data issue: false hasContentIssue false
  • English
  • Français

Quality Standard for Assurance of Measles Immunity Among Health Care Workers

Published online by Cambridge University Press:  02 January 2015

Peter J. Krause ,
Peter A. Gross ,
Trisha L. Barrett ,
E. Patchen Dellinger ,
William J. Martone ,
John E. McGowan Jr ,
Richard L. Sweet  and
Richard P. Wenzel
Peter J. Krause*
Affiliation:
Hartford Hospital, Hartford, andthe University of Connecticut School of Medicine, Farmington, Connecticut
Peter A. Gross
Affiliation:
Hackensack Medical Center, Hackensack, andNew Jersey Medical School, Newark, New Jersey
Trisha L. Barrett
Affiliation:
Alta Bates Medical Center, Berkeley, California
E. Patchen Dellinger
Affiliation:
University of Washington Medical Center, Seattle, Washington
William J. Martone
Affiliation:
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
John E. McGowan Jr
Affiliation:
Emory University School of Medicine, Atlanta, Georgia
Richard L. Sweet
Affiliation:
Magee Women's Hospital and, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Richard P. Wenzel
Affiliation:
University of Iowa Hospitals and Clinics, Iowa City, Iowa
*
Department of Pediatrics, Hartford Hospital, Hartford, CT 06115
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The objective of this quality standard is to prevent nosocomial transmission of measles by assuring universal measles-mumps-rubella (MMR) vaccination of all healthcare workers who lack immunity to measles. Although the primary emphasis is on healthcare workers in hospitals, those at other sites, such as clinics, nursing homes, and schools, are also included. It will be the responsibility of designated individuals at these institutions to implement the standard.

Options:

We considered advocating the use of measles vaccine rather than MMR but chose the latter because it also protects against mumps and rubella and because it is more readily available.

Outcomes:

The desired outcome is a reduction in the nosocomial transmission of measles.

Evidence:

Although direct comparative studies are lacking, nosocomial outbreaks of measles have been reported (as recently as 1992) in institutions where measles immunization of nonimmune healthcare workers is not universal, whereas such outbreaks have not been reported in institutions with universal immunization.

Values and Validation:

We consulted more than 50 infectious-disease experts in epidemiology, government, medicine, nursing, obstetrics and gynecology pediatrics, and surgery. In light of disagreement regarding the implementation of the standard, we used group discussions to reach a consensus.

Benefits, Harms, and Cost:

The consequences of the transmission of measles (and of mumps and rubella) in a healthcare institution include not only the morbidity and mortality attributable to the disease, but also the significant cost of evaluating and containing an outbreak and the serious disruption of regular hospital routines when control measures are instituted. The potential harm to healthcare workers after the implementation of the standard consists of untoward effects of MMR vaccine, although the reactions of vaccines should be minimal with adherence to recommended vaccination procedures. Implementation of the standard should entail no expense to healthcare workers; the precise cost to institutions is unknown, but the expense would be mitigated by prevention of measles outbreaks.

Recommendations:

We recommend MMR vaccination of all healthcare workers who lack immunity to measles.

Sponsors:

The Quality Standards Subcommittee of the Clinical Affairs Committee of the Infectious Diseases Society of America (IDSA) developed the standard. The subcommittee was composed of representatives of the IDSA (Drs. Gross and McGowan), the Society for Hospital Epidemiology of America (Dr. Wenzel), the Surgical Infection Society (Dr. Dellinger), the Pediatric Infectious Diseases Society (Dr. Krause), the Centers for Disease Control and Prevention (Dr. Martone), the Obstetrics and Gynecology Infectious Diseases Society (Dr. Sweet), and the Association of Practitioners of Infection Control (Ms. Barrett). Funding was provided by the IDSA and the other cooperating organizations. The standard is endorsed by the IDSA.

Type
Consensus Paper
Information
Infection Control & Hospital Epidemiology , Volume 15 , Issue 3 , March 1994 , pp. 193 - 199
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control. Measles prevention. MMWR 1989:38 (suppl 9): 1–8.Google Scholar
2.National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991;266:1547–1552.Google Scholar
3.Enguidanos, R, Mascola, L, Frederick, P, A survey of hospital infection control policies and employee measles cases during Los Angeles County's measles epidemic, 1987 to 1989. Am J Infect Control 1992;20:301–304.Google Scholar
4.Knight, P, Measles epidemic, vaccine shortfall stir up controversy. ASM News 1991;57:560–561.Google Scholar
5.Cherry, JD. Measles. In: Feigin, RD, Cherry, JD, eds. Textbook of Pediatric Infectious Diseases. 3rd ed. Philadelnhia. PA: WB Saunders, 1992:1591–1609.Google Scholar
6.Siegel, M, Fuerst, HTLow birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox. and hepatitis. JAMA 1966;197:680–684.Google Scholar
7.Jespersen, CS, Littauer, J, Sagild, U. Measles as a cause of fetal defects:a retrospective study of ten measles epidemics in Greenland. ActaPediatrScand 1977;66:367–372.Google Scholar
8.Centers for Disease Control. Rubella prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39(RR-15):1–18.Google Scholar
9.Centers for Disease Control. Mumps prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1989;38:388–400.Google Scholar
10.Arguedas, GA, Deveikis, AA, Marks, MI. Measles. Am J Infect Control 1991;19:290–298.Google Scholar
11.Weber, DJ, Rutala, WA, Orenstein, WA. Prevention of mumps, measles, and rubella among hospital personnel. J Pediatr 1991;119:322–326.Google Scholar
12.Rivera, ME, Mason, WH, Ross, LA, Wright, HT Jr. Nosocomial measles infection in a pediatric hospital during a community-wide epidemic. J Pediatr 1991;119:183–186.Google Scholar
13.Rank, EL, Brettman, L, Katz-Pollack, H, DeHertogh, D, Neville, D. Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989. Am /Infect Control 1992;20:315–318.Google Scholar
14.U.S. Department of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Boston, MA: Janes and Bartlett Publishers; 1992.Google Scholar
15.Siegel, CS. Measles: a review of the virological and serological methods for early detection. Clin Microbiol Newsletter 1991;13:177–179.Google Scholar
16.Houck, P, Scott-Johnson, G, Krebs, L. Measles immunity among community hospital employees. Infect Control Hasp Epidemiol 1991;12:663–668.Google Scholar
17.Subbarao, EK, Amin, S, Kumar, ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991;163:876–878.Google Scholar
18.Grabowsky, M, Markowitz, L. Serologic screening, mass immunization, and implications for immunization programs. J Infect Dis 1991;164:1237–1238. Letter.Google Scholar
19.Schwarcz, S, McCaw, B, Fukushima, I? Prevalence of measles susceptibility in hospital staff: evidence to support expanding the recommendations of the Immunization Practices Advisory Committee. Arch Intern Med 1992;152:1481–1483.Google Scholar
20.Atkinson, WL, Markowite, LE, Adams, NC, Seastrom, GR. Transmission of measles in medical settings-United States, 1985-1989. Am J Med 1991;91(suppl 3B):320S–324S.Google Scholar
21.Preblud, SR, Kate, SL. Measles vaccine In: Plotkin, SA, Mortimer, EA, eds. Vaccines. Philadelphia, PA: WB Saunders, 1988:182–222.Google Scholar
22.King, GE, Markowitz, LE, Patriarca, PA, Dales, LG. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991;10:883–888.Google Scholar
23.Krause, PJ, Cherry, JD, Deseda-Tbus, J, et al. Epidemic measles in young adults: clinical, epidemiologic, and serologic studies. Ann Intern Med 1979;90:873–876.Google Scholar
24.American Academy of Pediatrics. Report of the Committee on Infectious Diseases. Evanston, IL: American Academy of Pediatrics; 1991.Google Scholar
25.Griffin, MRRay, WA, Mortimer, GM, Fenichel, GM, Schaffner, W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 1991;88:881–885.Google Scholar
26.Chen, RT, Moses, JM, Markowitz, LE, Orenstein, WA. Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine 1991;9:297–299.Google Scholar
27.Tingle, AJ, Allen, M, Petty, RE. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunization. Ann Rheum Dis 1986;45:110–114.Google Scholar
28.Fasano, MB, Wood, RA, Cooke, SK, Sampson, HA. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine. J Pediatr 1992;120:878–881.Google Scholar
29.Hermann, JJ, Radin, R, Schneiderman, RAllergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 1983; 102:196–199.Google Scholar
30.Greenberg, MA, Birx, DL. Safe administration of mumps-measles-rubella vaccine in egg-allergic children. J Pediatr 1988; 113:504–506.Google Scholar
31.Beck, SA, Williams, LW, Shirrell, MA, Burks, AW. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics 1991;88:913–917.Google Scholar
32.Kaplan, LJ, Daum, RS, Samron, M, McCarthy, CA. Severe measles in immunocompromised patients. JAMA 1992;267:1237–1241.Google Scholar
33.Siber, GR, Werner, BG, Halsey, NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204–211.Google Scholar
34.Krause, PJ, Cherry, JD, Naiditch, MJ, Deseda-Tous, J, Walbergh, EW: Revaccination of previous recipients of killed measles vaccine; clinical and immunologic studies. J Pediatr 1978;93:565–571.Google Scholar
35.Centers for Disease Control. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR 1988;37:197–200.Google Scholar
36.Gross, PA, Barrett, TL, Dellinger, EP, et al. Consensus develop ment of quality standards. Infect Control Hosp Epidemiol 1994;15:180–181.Google Scholar